Vivanza Biosciences

I.  ADDITIONAL NOTES (Forming an integral part of Accounts)
 
 1. In opinion of the management of the company, all loans, advances and
 deposits are recoverable in cash or kind for value to be received for
 which no provision is required. However in the opinion of the Auditors,
 it shall be prudent to make sufficient provision for such non
 performing assets amounting to Rs. 59,33,061/-.
 
 2 Contingent liabilities for claims against company not acknowledged
 and not provided for amounts to Rs. 5,01,271/- (P.Y. Rs. 5,01,271/-).
 As ascertained and certified by the management there is no other
 contingent liability for which provision is required.
 
 3 Balance of all personal accounts including Sundry debtors, Sundry
 creditors, Loans and Advances, Deposits etc. are subject to
 confirmation, reconciliation and appropriate adjustment.
 
 4. The Composite Scheme of Re-organisation of Share Capital and
 Arrangement for Revival of the Company filed with the Stock Exchange
 and SEBI under Clause 24(f) of the Listing Agreement had been withdrawn
 by the Company in view of observations received from BSE requires
 revision of the Scheme.
 
 5.  Segment Report :
 
 The company is exclusively engaged in the business of manufacture and
 sale of I.V. fluids, Pharmaceuticals products in India and there is no
 other segmental activities hence no separate disclosure of reportable
 segment is required.